
    
      A multi-center, global, randomized, double-blind, double-dummy, active-controlled,
      parallel-group study in adult subjects with fluctuating PD. The study will have 2 open label
      Titration periods of 6 weeks each prior to the double blind Maintenance period. In the open
      label periods all patients will be stabilized on the active comparator SinemetÂ® and then on
      AP-CD/LD. The double blind Maintenance period will be 13 weeks long.
    
  